Discussion - Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA

10' education - July 6, 2022 - Prof. Johannes Mann, MD (Munich, Germany), prof. Filip Knop, MD, PhD (Copenhagen, Denmark), and prof. Katherine Tuttle, MD (Spokane, WA, USA)

Educational information

This discussion is part of a series titled "Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA"..

Faculty

Johannes Mann is professor of medicine at the University of Erlangen-Nürnberg, and affiliated at the KfH Kidney Center, Munich, Germany

Filip Krag Knop, MD, PhD, Professor of endocrinology and Director of Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Denmark.

Katherine Tuttle is Clinical Professor of Medicine, Nephrology, University of Washington at Spokane, WA, USA.

Disclosures

The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

This educational activity is intended for an international audience of non-US and non-UK HCPs

Funding

Funding for this educational program was provided by an unrestricted educational grant received from Novo Nordisk A/S.

Disclaimer

This educational activity is intended for an international audience of non-US and non-UK HCPs

Watch the presentations of this symposium

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.